LEADER 01100nam0-2200385---450-
001 990000360620203316
010   $a0-443-05974-8
035   $a0036062
035   $aUSA010036062
035   $a(ALEPH)000036062USA01
035   $a0036062
100   $a20010315d1999----km-y0itay0103----ba
101   $aeng
102   $aGB
105   $a||||||||001yy
200 1 $aPharmacology$fH.P. Rang, M.M. Ritter, J.M. Ritter$gillustrations by Peter Lamb
205   $a4. ed
210   $aEdinburgh [etc.]$cChurchill Livingstone$d1999
215   $aX, 830 p.$d26 cm
606 0 $aFarmacologia
676   $a615.1
700  1$aRANG,$bH.P.$0101179
701  1$aDALE,$bM.M.$0543544
701  1$aRITTER,$bJ.M.$0101182
801  0$aIT$bsalbc$gISBD
912   $a990000360620203316
951   $a615.1 RAN$b2546 Farm.$c615.1$d00070814
959   $aBK
969   $aFAR
979   $aTAMI$b40$c20010315$lUSA01$h1242
979   $aTAMI$b40$c20010315$lUSA01$h1243
979   $c20020403$lUSA01$h1644
979   $aPATRY$b90$c20040406$lUSA01$h1625
996   $aPharmacology$9876858
997   $aUNISA

LEADER 01124nam a2200289 i 4500
001 991001333899707536
005 20020507191544.0
008 950306s1971    de            ||| | fre  
035   $ab10832981-39ule_inst
035   $aLE01310663$9ExL
040   $aDip.to Matematica$beng
082 0 $a515.94
084   $aAMS 32-06
084   $aAMS 32-XX
100 1 $aLelong, Pierre$042866
245 10$aSéminaire Pierre Lelong (Analyse) :$bannée 1970 /$c[ed.] Institut Henri Poincaré, Paris ; [avant-propos Pierre Lelong]
260   $aBerlin ; Heidelberg ; New York :$bSpringer-Verlag,$c1971
300   $avi, 243 p. ;$c25 cm
490 0 $aLecture notes in mathematics,$x0075-8434 ;$v205
650  0$aFunctional analysis$xCongresses
650  0$aSeveral complex variables$xCongresses
907   $a.b10832981$b23-02-17$c28-06-02
912   $a991001333899707536
945   $aLE013 32-XX LEL13 (1971)$g1$i2013000024127$lle013$o-$pE0.00$q-$rl$s-  $t0$u0$v0$w0$x0$y.i10942075$z28-06-02
996   $aSéminaire Pierre Lelong (Analyse)$9923499
997   $aUNISALENTO
998   $ale013$b01-01-95$cm$da  $e-$ffre$gde $h0$i1